Addex Therapeutics Statistics
Total Valuation
ADXN has a market cap or net worth of $6.64 million. The enterprise value is $2.40 million.
Important Dates
The next confirmed earnings date is Friday, November 22, 2024, before market open.
Earnings Date | Nov 22, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ADXN has 98.30 million shares outstanding. The number of shares has increased by 50.83% in one year.
Current Share Class | n/a |
Shares Outstanding | 98.30M |
Shares Change (YoY) | +50.83% |
Shares Change (QoQ) | +72.24% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 34.24M |
Valuation Ratios
The trailing PE ratio is 1.38.
PE Ratio | 1.38 |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | 0.47 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 0.50 |
EV / Sales | 2.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.00.
Current Ratio | 4.97 |
Quick Ratio | 4.67 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -513.81 |
Financial Efficiency
Return on equity (ROE) is -126.29% and return on invested capital (ROIC) is -73.55%.
Return on Equity (ROE) | -126.29% |
Return on Assets (ROA) | -61.71% |
Return on Capital (ROIC) | -73.55% |
Revenue Per Employee | $41,767 |
Profits Per Employee | $208,904 |
Employee Count | 23 |
Asset Turnover | 0.08 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.00% in the last 52 weeks. The beta is 1.87, so ADXN's price volatility has been higher than the market average.
Beta (5Y) | 1.87 |
52-Week Price Change | +23.00% |
50-Day Moving Average | 9.95 |
200-Day Moving Average | 10.47 |
Relative Strength Index (RSI) | 28.14 |
Average Volume (20 Days) | 58,175 |
Short Selling Information
Short Interest | 3,461 |
Short Previous Month | 9,886 |
Short % of Shares Out | 0.41% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.14 |
Income Statement
In the last 12 months, ADXN had revenue of $960,641 and earned $4.80 million in profits. Earnings per share was $0.05.
Revenue | 960,641 |
Gross Profit | -6.80M |
Operating Income | -12.47M |
Pretax Income | -12.96M |
Net Income | 4.80M |
EBITDA | -12.32M |
EBIT | -12.47M |
Earnings Per Share (EPS) | $0.05 |
Full Income Statement Balance Sheet
The company has $4.22 million in cash and $35,813 in debt, giving a net cash position of $4.18 million or $0.04 per share.
Cash & Cash Equivalents | 4.22M |
Total Debt | 35,813 |
Net Cash | 4.18M |
Net Cash Per Share | $0.04 |
Equity (Book Value) | 14.08M |
Book Value Per Share | 0.14 |
Working Capital | 4.17M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$8.71 million and capital expenditures -$2,095, giving a free cash flow of -$8.86 million.
Operating Cash Flow | -8.71M |
Capital Expenditures | -2,095 |
Free Cash Flow | -8.86M |
FCF Per Share | -$0.09 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -1,298.01% |
Pretax Margin | -1,373.53% |
Profit Margin | 500.17% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -576.02% |
Dividends & Yields
ADXN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -50.83% |
Shareholder Yield | -50.83% |
Earnings Yield | 72.37% |
FCF Yield | -133.45% |
Analyst Forecast
The average price target for ADXN is $30.00, which is 306.50% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $30.00 |
Price Target Difference | 306.50% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on October 23, 2023. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Oct 23, 2023 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
ADXN has an Altman Z-Score of -32.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -32.87 |
Piotroski F-Score | 2 |